058820.KQ

CMG Pharmaceutical Co., Ltd. [058820.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

058820.KQ Stock Summary

Top 10 Correlated ETFs

058820.KQ

Top 10 Correlated Stocks

058820.KQ

In the News

058820.KQ Financial details

Company Rating
-
Market Cap
243.37B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
18 Mar 2021
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
5.24%
SMA50
11.42%
SMA100
5.64%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
108.89M
Shs Float
102.99M
-
-
-
-
Target Price
-
52W Range
1900.0-3080.0
52W High
-27.27%
52W Low
+17.89%
RSI
45.78
Rel Volume
0.35
Avg Volume
576.55K
Volume
200.47K
Perf Week
-4.48%
Perf Month
3.46%
Perf Quarter
-4.48%
Perf Half Y
0.67%
-
-
-
-
Beta
0.880055
-
-
Volatility
39.16%, 73.28%
Prev Close
0.45%
Price
2240
Change
-1.54%

Something similar

Top by Market Cap
ABEA.DE
VTSAX
EMBASSY.NS
MSF.DE
FB2A.DE
Top Correlated ETFs
364970.KS
Top Correlated Stocks
002620.KS
KIT.OL
8070.SR
8260.SR
091990.KQ
Similar Market Cap
SWED-A.ST
4182.T
131970.KQ
001250.KS
3923.T

Company Profile

  • Volume Average 576.55K
  • Market Capitalization 243.37B
  • CEO Jung-Gook Kim
  • Headquarters Seoul,KR
  • IPO Date 2001-09-03
  • Website https://www.cmgpharma.co.kr

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.